EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vaccination strategies to achieve outbreak control for MPXV Clade I with a one-time mass campaign in sub-Saharan Africa: A scenario-based modelling study

Shihui Jin iD, Toshiaki R Asakura iD, Hiroaki Murayama iD, David Niyukuri, Diafuka Saila-Ngita iD, Jue Tao Lim iD, Akira Endo iD, Borame L Dickens iD

PLOS Medicine · 2025

DOI: 10.1371/journal.pmed.1004726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Medicine, 2025. Verfasst von Shihui Jin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore. Hauptthemen laut MEDLINE: Disease Outbreaks, Mass Vaccination, Mpox, Monkeypox, Smallpox Vaccine. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education - Singapore, Singapore Ministry of Health, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Limited mpox vaccination coverage, declining cross-protection from historical smallpox vaccination campaigns, and persistent zoonotic reservoirs leave many sub-Saharan countries susceptible to mpox outbreaks. With millions of vaccine doses made available to the region since late 2024 and the absence of country-specific guidelines for allocation, estimating the country-specific impact of one-time mass vaccination strategies is necessary for ongoing outbreaks and other countries at future risk. Methods and findings We adapted a next generation matrix model to project disease transmission potential for 47 sub-Saharan countries from 2025 to 2050 under four transmission scenarios with different contributions of community versus sexual contacts. The model was informed by mpox datasets from Clade Ia and Ib outbreaks in the Democratic Republic of Congo (DRC), and incorporated country-specific demographics, contact patterns, and historical smallpox vaccination coverage. We then assessed strategies to reduce disease transmissibility by calculating country-specific minimum vaccine coverages and evaluating one-time, age-specific mass vaccination campaigns. At least 20 of the 47 countries are estimated to require vaccination in 2025, and 36 in 2050, to guard against potentially forthcoming national outbreaks. For 11 Clade I-affected countries, the minimum required coverage is estimated to range from 0%–4.8% to 14.5%–19.5% in 2025 with increasing sexual transmission, rising to 0%–10.8% and 22.6%–26.0% in 2050, respectively. The prioritised age group for vaccination shifts from 0–4 years to 20–29 years with additional sexual transmission. Note that all the projections were based on the best available evidence of Clade I transmission in the DRC as of December 2024.

Interpretation

With diminishing smallpox-vaccination-induced immunity, increasing disease transmissibility and potential for persistent outbreaks are expected for mpox, necessitating growing vaccine demand for outbreak containment. Given probable supply constraints, our findings could guide the ongoing and future mass vaccination efforts in sub-Saharan Africa by emphasising the prioritisation of high-risk groups, where allocation strategies are tailored to the evolving epidemiological landscape of each country.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease OutbreaksMass VaccinationMpox, MonkeypoxSmallpox VaccineVaccinia virusHumansAfrica South of the SaharaAdultAdolescentMaleFemaleYoung AdultChildMiddle AgedChild, PreschoolInfantVaccination

Substanzen

Smallpox Vaccine

Autor:innen und Institutionen

  • Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.
  • Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
  • School of Medicine, International University of Health and Welfare, Narita, Japan.
  • Doctoral School, University of Burundi, Bujumbura, Burundi.

ORCID-Profile: Shihui Jin, Toshiaki R Asakura, Hiroaki Murayama, Diafuka Saila-Ngita, Jue Tao Lim, Akira Endo, Borame L Dickens

Förderung

  • Ministry of Education - Singapore
  • Singapore Ministry of Health
  • Japan Science and Technology Agency
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Rotary Foundation
  • Japanese Ministry of Education, Culture, Sports, Science and Technology
  • JSPS KAKENHI Grant-in-Aid

Zitieren

APA

Jin, S., Asakura, T. R., Murayama, H., Niyukuri, D., Saila-Ngita, D., Lim, J. T., Endo, A., & Dickens, B. L. (2025). Vaccination strategies to achieve outbreak control for MPXV Clade I with a one-time mass campaign in sub-Saharan Africa: A scenario-based modelling study. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1004726

Vancouver

Jin S, Asakura TR, Murayama H, Niyukuri D, Saila-Ngita D, Lim JT, et al. Vaccination strategies to achieve outbreak control for MPXV Clade I with a one-time mass campaign in sub-Saharan Africa: A scenario-based modelling study. PLOS Medicine. 2025. doi:10.1371/journal.pmed.1004726

BibTeX
@article{Jin2025,
  author = {Jin, Shihui and Asakura, Toshiaki R and Murayama, Hiroaki and Niyukuri, David and Saila-Ngita, Diafuka and Lim, Jue Tao and Endo, Akira and Dickens, Borame L},
  title = {Vaccination strategies to achieve outbreak control for MPXV Clade I with a one-time mass campaign in sub-Saharan Africa: A scenario-based modelling study},
  journal = {PLOS Medicine},
  year = {2025},
  doi = {10.1371/journal.pmed.1004726}
}
Kostenlos starten →